MLH1 promoter methylation is a well-known epigenetic alteration in the tumorigenesis of colorectal cancer (CRC) and endometrial cancer (EC), the two most recurrent tumors found in Lynch syndrome (LS) patients. The gene discussed is MLH1; the disease is Lynch syndrome.